HIV Cure News: Genetically Altered Proteins Stop The Spread Of HIV Cells

Source: iTech Post

The Human Immunodeficiency Virus is spreading almost like wildfire. Countries that had minimal HIV cases now see those numbers growing. There is no doubt that the urgency to find a cure is pressing. Fortunately, a group of scientists, from the University of Oxford, are developing a cure that will not only stop the spread of HIV, but will also kill HIV cells.

The treatment was first caught on by a British company, which scientists at the University of Oxford have expounded on. According to Nature World News, the study centers around modified protein cells called the immune-mobilizing T cell receptors-based drugs (ImmTAVs). These cells are two-headed proteins that, when provided to an HIV-positive individual, could help his or her immune system eradicate the HIV cells.

One head of the ImmTAV is meant to locate these HIV-infected cells. Even at low levels, it is possible. The other head contains the antibody that attaches to CD3 and kills the cells. CD3, or cluster of differentiation 3, is a multimeric protein complex. More

11/7/2016

Medicines Patent Pool expands access to HIV, hepatitis C drugs with new deals

Source: BioPharma Dive

The Medicines Patent Pool has signed sub-licensing deals with seven generic drugmakers in India and China to make copycat versions of four HIV treatments and a hepatitis C drug made by Bristol-Myers Squibb.

Bristol-Myers agreed to license its hepatitis C drug Daklinza to the MPP in November 2015, giving the organization the ability to sign deals with generic drugmakers to produce generic versions of the drug in 112 low- and middle-income countries. Daklinza is the first hepatitis C drug in the MPP.

The generic manufacturers involved in last week's agreements include the Indian manufacturers Aurobindo, Emcure, Hetero Labs, Laurus and Lupin, as well as Shanghai, China-based Desano.More

11/7/2016

China's Only AIDS Ride Survivor

Source: City Weekend

Liu Jiulong rolled into Beijing last month to cheers and the flash of paparazzi, becoming the only person to complete every AIDS Ride China has seen. (That would be two.)

The journey took Liu and his photographer boyfriend Boa Yong from the depths of human depravity to hopes of acceptance in China.

On stage, Liu told his tale: infection while working in the Pearl River Delta, diagnosis in Beijing, a suicide attempt with sleeping pills, friends who rushed him to get his stomach pumped, and the loss of his job 10 days after sharing his diagnosis.